Fundraising Fox
iCHOR
North Webster, US · Founded 2014 · 4 known investors
Find your way into iCHOR
Sign up to see every warm intro you have to iCHOR
- Paths you didn't know you had: your email and LinkedIn already hold routes to the iCHOR team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iCHOR develops minimally-invasive mechanical thrombectomy systems for treating peripheral vascular occlusions, converting traditional open surgical techniques into endovascular procedures for patients with arterial and venous disease.
Founders & leadership
iCHOR was founded in 2014 by Dr. Troy Long and Tim Blair.
DT
Dr. Troy LongFounder
TB
Tim BlairFounderTim Blair is founder and CEO of iCHOR Vascular, a medical device company developing minimally-invasive mechanical thrombectomy systems for peripheral vascular disease. He brings over 30 years of experience in medical device leadership, including prior roles managing P&Ls in the cardiovascular and vascular markets, and has led FDA regulatory approvals and commercialization across multiple product platforms.
Investors · 4
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 2 rounds · 2016–2024
▶$2.9MraisedFeb 2024 · 54 investors · Other Health CareRule 506(b)
▶$2.9MraisedFeb 2024 · 54 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy BlairExecutive Officer, Director
- Andrew GreenfieldDirector
- Craig BerkyDirector
- Troy LongDirector
- Mark PetersonDirector
- Surindra MitrukaDirector
- Jeffrey BlairDirector
- Offering amount
- $6M
- Amount sold
- $2.9M
- Minimum investment
- $5K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$202.5KraisedMay 2016 · 4 investors · Other Health CareRule 506(b)
▶$202.5KraisedMay 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- TROY LONGExecutive Officer, Director
- JEFF BLAIRExecutive Officer, Director
- Offering amount
- $202.5K
- Amount sold
- $202.5K
- First sale
- Apr 2016
- Incorporated
- Corporation, Minnesota, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does iCHOR do?
- iCHOR develops minimally-invasive mechanical thrombectomy systems for treating peripheral vascular occlusions, converting traditional open surgical techniques into endovascular procedures for patients with arterial and venous disease.
- Who founded iCHOR?
- iCHOR was founded by Dr. Troy Long, Tim Blair in 2014.
- Who are iCHOR's investors?
- iCHOR's investors include Alliance of Angels, Arieal Southeast Angel Partners, Band of Angels, Central Texas Angel Network.
- How much funding has iCHOR raised?
- iCHOR has disclosed $3.1M raised across 2 rounds.
- Where is iCHOR headquartered?
- iCHOR is headquartered in North Webster, US.